$11.0M
The round was led by We Venture Capital and Cross-Border Impact Ventures to support the development of liquid biopsy tests.
O
OXcan
Oxford Cancer Analytics develops blood tests for early cancer detection.
Oxford, UK—Founded 2020
$11.0MTotal raised
Oxford Cancer Analytics develops protein based blood tests for the early detection of lung cancer using advanced proteomics and artificial intelligence.
Categories
Team
PL
Peter Liu
Co-founder
AH
Andreas Halner
Co-founder
DS
Daniel Szulc
Chief Product Officer
BW
Brad Wilson
Chairman